Dupixent brand name Dupixent Eczema Injection 300 mg Manufactured Dupixent Eczema by Dupilumab. Here Dupixent Dupilumab 300 mg cost in India best at Yourmedikart. Uses Moderate-to-severe atopic Dermatitis. And Dupilumab brands in India Injection 300 mg Manufactured injection for eczema in India by Dupilumab. Dupixent Dupilumab cost and Dupixent 300 mg price in India best at Yourmedikart.

 DUPIXENT 300 MG

GENERIC NAME: Dupilumab

Upsides

• May be used to treat Moderate-to-severe eczema (atopic Dermatitis) in adults and dupixent injection price children aged 6 months and older when other topical Therapies are not effective or Advisable. May be used with or without topical Corticosteroids.
• May also be used for moderate-to-severe eosinophilic asthma (this is asthma Associated with high levels of white blood cells known as eosinophils) or oral corticosteroid-dependent asthma as an add-on maintenance treatment in adults and children aged 6 years of age and older.
• Dupixent does NOT treat an asthma attack.
• Dupilumab injection price in India uses Moderate-to-severe atopic Dermatitis, Dupixent price India Moderate-to-severe asthma, Dupixent injection price severe chronic Rhinosinusitis with nasal polyps.
• Can be used in addition to other treatments for chronic Rhinosinusitis Associated with nasal polyps in adults and Eosinophilic esophagitis in adults and children aged 12 years and older, who weigh at least 40 kg.
• Is the first treatment (and currently the only) treatment Approved to treat Prurigo Nodularis, a chronic, Debilitating skin disease that has a significant impact on a person’s quality of life.

• Steroid-free.

• Administered by Subcutaneous injection (under the skin). Dupixent 300 mg Price Indicated when Dermatitis is not Adequately controlled with topical Prescription Therapies or when those Therapies are not Advisable.
• Available as a pre-filled syringe or pre-filled pen. The pre-filled pen is only for use in patients 12 years of age and older. The pre-filled pen contains a 300 mg dose. The pre-filled syringe comes in doses of 200 mg or 300 mg.
• People prescribed Dupixent can be taught how to self-administer the Injection.
• Usually given every two weeks (every other week). In children weighing 15kg to less than 30kg, it is recommended Dupixent be given every four weeks.
• Not considered an immunosuppressant because it does not suppress the immune system.
• Not a cure for eczema but it does reduce symptoms (such as itching, rash, flare frequency) in two-thirds to three-fourths of people prescribed it. But there does appear to be a subset of people who only partially respond to Dupixent (partial responders), or who respond initially, and then their symptoms return (non-durable responders). Dupixent Dupilumab 300 mg eczema injection cost in India is available under the following different brand names: Dupixent. Dupixent Dupilumab 300 mg eczema injection cost in India is best at online.

Info

• A patient may Self-inject DUPIXENT—or a caregiver may administer DUPIXENT injection—after training has been provided by a healthcare provider on proper Subcutaneous injection technique using the pre-Filled syringe or pre-filled pen.
  • The DUPIXENT Injection Pre-filled syringe should give by a Caregiver in children younger than 12 years of age.
  • In Adolescents 12 years of age and older, dupilumab tablet is Recommended that DUPIXENT Administer by or under the Supervision of an adult.
• It is important to provide proper training to patients and/or Caregivers on the preparation and Administration of DUPIXENT prior to use
• After administration, advise patients to follow sharps disposal recommendations.
• Patients and/or caregivers should read the Instructions for Use—either 200 mg or 300 mg pre-filled pen or pre-filled syringe—prior to injecting
• Consider completing all age-appropriate vaccinations as recommended by current immunization guidelines prior to initiating treatment with DUPIXENT Injection.

Atopic Dermatitis

• Indicated for moderate-to-severe atopic Dermatitis not Adequately controlled with topical Prescription therapies or when those therapies not advisable. Dupixent injection in India available at online. Dupixent India Moderate-to-severe asthma, severe chronic Rhinosinusitis with nasal polyps. 
• 600 mg (ie, two 300-mg injections) SC once, and then 300 mg SC every other week
• Can use with or without topical Corticosteroids.

Moderate-to-Severe Asthma

• Indicated as add-on Maintenance treatment for Patients with Eosinophilic Phenotype or PO Corticosteroid Dependent Asthma
• 400 mg SC once, then 200 mg q2weeks, OR
• 600 mg SC once, then 300 mg q2weeks
• 600 mg initial, then 300 mg q2weeks for patients with PO Corticosteroid-Dependent Asthma or Comorbid Moderate-to-Severe Atopic Dermatitis (for which Dupilumab is indicated)

Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

• Indicated as add-on Maintenance Treatment
• 300 mg SC q2Weeks

Eosinophilic Esophagitis

• Indicated for Eosinophilic Esophagitis
• 300 mg SC Week

Dosing Considerations

Topical calcineurin inhibitors may use, for topical Dermatitis, but should Reserve for Problem areas only (eg, face, neck, Intertriginous, and genital areas)

Not indicated for acute Bronchospasm or status Asthmaticus

Vaccinations

• Consider Completing all age-Appropriate Vaccinations as Recommended by Current Immunization Guidelines before Initiating Treatment

Orphan Designations

Bullous Pemphigoid

Dupilumab 600 mg

• The Dupilumab cost can vary depending on the market, with options for Dupilumab injections available for individuals’ requiring treatment. You can also explore the Dupilumab costo for more detailed pricing.
• The brand name Dupixent is widely known, with the Dupixent prezzo fluctuating based on regions. The Dupixent 300 mg price in India, for example, is different from other markets.
• Patients may choose Dupilumab injection forms or opt for Dupilumab tablet alternatives, depending on their treatment needs.
• For those looking to acquire Dupixent 300 mg price in India, it’s crucial to check the current rates and compare them to the Dupilumab prezzo or Dupilumab fiyat.
• The Dupilumab injection price tends to be higher but is available across different regions. In Dupixent India, the Dupixent 300 mg price in India is a key consideration for those needing long-term care.
• While Dupixent cost may seem high, options like Dupixent tablet and injection forms are widely prescribed. For Indian patients, the Dupilumab cost in India and Dupixent in India are crucial factors to explore, particularly when managing their condition.
• Dupixent injection sites are typically specified by healthcare providers, and the Dupixent injection price can vary depending on the dosage and region. It’s important to note that the Dupilumab price is often dependent on the specific dosage, such as Dupixent 300 mg price.
• Lastly, for those seeking affordability, comparing the Dupixent injection price in India with other markets might help reduce Dupixent cost in India while still ensuring access to the right treatment, like Dupixent 300 mg.

USE IN SPECIFIC POPULATIONS

• Pregnancy: A pregnancy exposure registry monitors pregnancy outcomes in women exposed to Dupixent 300 mg during pregnancy. Go to Mother to baby Available data from case reports and case series with DUPIXENT use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.
• Human IgG antibodies are known to cross the placental barrier; therefore, DUPIXENT eczema may transmitted from the mother to the developing fetus.
• Lactation: There are no data on the presence of Dupixent 300 mg in human milk, the effects on the breastfed infant, or the effects on milk production. Maternal IgG is know to present in human milk. The Developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for DUPIXENT and any potential adverse effects on the breastfed child from DUPIXENT or from the underlying maternal condition.

INDICATIONS

• Atopic Dermatitis: Dupixent 300 mg price in india best online and is indicated for the treatment of adult and Pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis whose disease is not Adequately controlled with topical prescription therapies or when those therapies are not advisable. DUPIXENT can use with or without topical Corticosteroids.
• Asthma: Dupixent 300 mg is indicated as an add-on maintenance treatment of adult and pediatric patients aged 6 years and older with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid dependent asthma. Limitation of Use: DUPIXENT is not indicated for the relief of acute bronchospasm or status asthmaticus.
• Chronic Rhinosinusitis with nasal polyposis (CRSwNP): DUPIXENT Eczema is indicated as an add-on Maintenance treatment in adult patients with inadequately controlled CRSwNP.
• Eosinophilic Esophagitis: DUPIXENT 300 mg is indicated for the treatment of adult and pediatric patients aged 12 years and older, weighing at least 40 kg, with eosinophilic esophagitis.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATION: 

DUPIXENT 300 mg is contraindicated in patients with known hypersensitivity to Dupilumab or any of its excipients.

Warnings and Precautions

Hypersensitivity: Hypersensitivity reactions, including anaphylaxis, serum sickness or serum sickness-like reactions, angioedema, generalized urticaria, rash, erythema nodosum, and erythema Multiforme have report. However, if a Clinically Significant Hypersensitivity reaction occurs, Institute Appropriate therapy and Discontinue DUPIXENT Eczema.

Dupixent eczema injection 300 mg manufactured by Dupilumab. Dupixent Dupilumab cost and Price in india best at Yourmedikart.

Conjunctivitis and Keratitis:

• Conjunctivitis and keratitis occurred more Frequently in atopic dermatitis subjects who received DUPIXENT eczema versus placebo, with conjunctivitis the most frequently reported eye disorder.
• Also occurred more frequently in chronic rhinosinusitis with nasal polyposis subjects who received DUPIXENT injection compared to those who received placebo.
• Conjunctivitis and keratitis have report with DUPIXENT injection post marketing settings, predominantly in atopic dermatitis patients. Some patients reported visual disturbances (e.g., blurred vision) associated with conjunctivitis or keratitis.
• Advise patients to report new onset or worsening eye symptoms to their healthcare provider. Consider ophthalmological examination for patients who develop conjunctivitis that does not resolve following standard treatment or signs and symptoms suggestive of keratitis, as appropriate.

Eosinophilic Conditions:

•  Patients treat for asthma may present with serious systemic Eosinophilia Sometimes presenting with clinical features of eosinophilic pneumonia or vasculitis consistent with eosinophilic granulomatosis with Polyangiitis (EGPA), conditions which are treat with systemic corticosteroid therapy.
• These events may associate with the reduction of oral corticosteroid therapy.
• Healthcare providers should alert to vasculitis rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients with eosinophilia.
• Cases of eosinophilic pneumonia were report in adult subjects who participate in the asthma development program and cases of vasculitis consistent with EGPA have report with DUPIXENT in adult subjects who participate in the asthma development program as well as in adult subjects with co-morbid.
• Asthma in the CRSwNP development program. A causal association between DUPIXENT and these conditions has not established.

Acute Asthma Symptoms or Deteriorating Disease: 

• Do not use DUPIXENT eczema to treat acute asthma symptoms, acute exacerbations, acute bronchospasm or status asthmaticus. Patients should seek medical advice if their asthma remains uncontrolled or worsens after initiation of DUPIXENT.
• Risk Associate with Abrupt Reduction of Corticosteroid Dosage: Do not discontinue systemic, topical, or inhaled corticosteroids abruptly upon initiation of DUPIXENT. Reductions in corticosteroid dose, if appropriate, should gradual and perform under the direct supervision of a healthcare provider.
• Dupixent eczema injection 300 mg manufactured by Dupilumab. Dupilumab cost in india Uses moderate-to-severe atopic dermatitis. Reduction in corticosteroid dose may associate with systemic withdrawal symptoms and/or unmask conditions previously suppress by systemic corticosteroid therapy.
• Patients with Co-morbid Asthma: Advise Patients with comorbid asthma not to adjust or stop their asthma treatments without consultation with their physicians.
• Arthralgia: Arthralgia has report with the use of DUPIXENT with some patients reporting gait. Disturbances or decrease mobility associate with joint symptoms; some cases result in hospitalization. Advise patients to report new onset or worsening joint symptoms. If symptoms persist or worsen, consider Rheumatological evaluation and/or discontinuation of DUPIXENT.

Parasitic (Helminth) Infections:

• Firstly, it is unknown if DUPIXENT Eczema will influence the immune response against helminth infections. Treat patients with pre-existing helminth infections before initiating therapy with DUPIXENT Injection If patients become infected while receiving treatment with DUPIXENT and do not respond to anti-helminth treatment, discontinue treatment with DUPIXENT Injection until the infection resolves.
• Helminth infections were report in pediatric patients 6 to 11 years old in the pediatric asthma development program.
• Vaccinations: Consider completing all age-appropriate vaccinations as recommended by current immunization guidelines prior to initiating DUPIXENT. Because Avoid use of live vaccines in patients treated with DUPIXENT.

Adverse Reactions:

• Atopic Dermatitis: The most Common adverse reactions (incidence ≥1%) in patients are Injection site reactions. Conjunctivitis, blepharitis, oral herpes, keratitis, eye pruritus, other her.
• Secondly Simplex virus infection, dry eye, and Eosinophilia. The safety Profile in Pediatric Patients Through Week 16 was Similar to that of Adults with Atopic Dermatitis. In an open-label Extension study
• The long-term safety profile of DUPIXENT Eczema ± TCS in Pediatric Patients observe through Week 52 was Consistent. With that seen in adults with atopic Dermatitis, with hand-foot-and-mouth disease and skin Papilloma (incidence ≥2%) report in patients 6 months to 5 years of age.
• Dupixent Dupilumab cost in India best at Yourmedikart These cases did not lead to study drug Discontinuation.
• Asthma: The most common adverse reactions (Incidence ≥1%) are Injection site Reactions, Oropharyngeal pain, and Eosinophilia.
• Chronic Rhinosinusitis with Nasal Polyposis: The most common Adverse Reactions (Incidence ≥1%) are Injection site Reactions, Eosinophilia, Insomnia, toothache, gastritis, arthralgia, and conjunctivitis.
• Eosinophilic Esophagitis: The most common Adverse reactions are Injection site reactions, So upper Respiratory tract infections, Arthralgia, and herpes viral infections.

FAQ

What is Dupixent used for?

DUPIXENT is a prescription medicine used: to treat adults and children 6 months of age and older with severe atopic dermatitis (eczema) that is not well controlled by prescription (topical) skin treatments or cannot be treated with medications do something. treatment.

Is Dupixent a type of steroid?

It is not a steroid. DUPIXENT is different: the only targeted biological therapy for moderate to severe asthma. It is taken by injection under the skin (subcutaneous injection). It is considered different from oral and inhaled steroids.

Is Dupixent safe?

Conclusion. Dupixent is an injection usually given under the skin every two weeks to treat asthma, eczema, and some other inflammatory conditions. Injection site reactions and eye conditions are the most commonly reported side effects, and, unlike many other living conditions, the risk of infection is low.

Is Dupixent injection painful?

The injections do hurt very bad. The medicine burns going in.

Where do you inject Dupixent?

You can sew on your thighs or stomach, except for 2 inches (5 cm) around your navel (belly button). If your caregiver injects your dose, they may also use the outer area of the upper arm. Choose a different site each time you run DUPIXENT. Do not apply to sensitive, broken, sore or bruised skin.

Dupixent 300 mg price